Roche Posts Double-Digit Increase in Full-Year Applied Science Revenues, Dip in MDx

Revenues for the company's diagnostics group increased 3 percent. This division includes molecular diagnostics, which posted a 2 percent dip in revenues, and applied sciences, which recorded an 11 percent increase in sales.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories